Cargando…

High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial

Background: Fatigue is a common symptom in patients with Multiple system atrophy (MSA), but effective treatments remain elusive. The present study aims to investigate whether high-frequency repetitive transcranial magnetic stimulation (rTMS) over the left dorsolateral prefrontal cortex (DLPFC) could...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jing, Mi, Tao-Mian, Ma, Jing-Hong, Sun, Hong, Chan, Piu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788320/
https://www.ncbi.nlm.nih.gov/pubmed/35087463
http://dx.doi.org/10.3389/fneur.2021.755352
_version_ 1784639537305092096
author Pan, Jing
Mi, Tao-Mian
Ma, Jing-Hong
Sun, Hong
Chan, Piu
author_facet Pan, Jing
Mi, Tao-Mian
Ma, Jing-Hong
Sun, Hong
Chan, Piu
author_sort Pan, Jing
collection PubMed
description Background: Fatigue is a common symptom in patients with Multiple system atrophy (MSA), but effective treatments remain elusive. The present study aims to investigate whether high-frequency repetitive transcranial magnetic stimulation (rTMS) over the left dorsolateral prefrontal cortex (DLPFC) could relieve fatigue in patients with MSA. Methods: This is a single-center, randomized and double-blind trial. Twenty-two patients with MSA and fatigue were randomly allocated to receive 10 sessions of either active (N = 11) or sham (N = 11) 10 Hz rTMS over the left DLPFC. The participants were assessed at baseline (T0), after the last session of treatment (T1), and at 2-week (T2), and 4-week (T3) follow-up timepoints. The primary outcomes were Fatigue Severity Scale-9 (FSS-9) scores, with Unified Multiple System Atrophy Rating Scale (UMSARS), 17-item Hamilton Depression Scale (HAMD-17), and Hamilton Anxiety Scale (HAMA) as secondary outcomes. Results: Two-way repeated ANOVAs revealed significant group × time interactions for FSS-9 scores (p < 0.001), HAMD-17 scores (p = 0.01), HAMA scores (p = 0.01), and UMRSA part II (p = 0.05). Post-hoc analyses showed that compared to T0, the active group exhibited remarkable improvements in FSS-9 and UMRSA part II scores at T1 and T2, but not at T3, and also in HAMD-17 and HAMA scores at T1, T2, and T3. No significant improvement was found in the sham group. Conclusion: High-frequency rTMS over the left DLPFC could provide short-term improvements for alleviating fatigue in patients with MSA, but the beneficial effects last no more than 4 weeks.
format Online
Article
Text
id pubmed-8788320
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87883202022-01-26 High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial Pan, Jing Mi, Tao-Mian Ma, Jing-Hong Sun, Hong Chan, Piu Front Neurol Neurology Background: Fatigue is a common symptom in patients with Multiple system atrophy (MSA), but effective treatments remain elusive. The present study aims to investigate whether high-frequency repetitive transcranial magnetic stimulation (rTMS) over the left dorsolateral prefrontal cortex (DLPFC) could relieve fatigue in patients with MSA. Methods: This is a single-center, randomized and double-blind trial. Twenty-two patients with MSA and fatigue were randomly allocated to receive 10 sessions of either active (N = 11) or sham (N = 11) 10 Hz rTMS over the left DLPFC. The participants were assessed at baseline (T0), after the last session of treatment (T1), and at 2-week (T2), and 4-week (T3) follow-up timepoints. The primary outcomes were Fatigue Severity Scale-9 (FSS-9) scores, with Unified Multiple System Atrophy Rating Scale (UMSARS), 17-item Hamilton Depression Scale (HAMD-17), and Hamilton Anxiety Scale (HAMA) as secondary outcomes. Results: Two-way repeated ANOVAs revealed significant group × time interactions for FSS-9 scores (p < 0.001), HAMD-17 scores (p = 0.01), HAMA scores (p = 0.01), and UMRSA part II (p = 0.05). Post-hoc analyses showed that compared to T0, the active group exhibited remarkable improvements in FSS-9 and UMRSA part II scores at T1 and T2, but not at T3, and also in HAMD-17 and HAMA scores at T1, T2, and T3. No significant improvement was found in the sham group. Conclusion: High-frequency rTMS over the left DLPFC could provide short-term improvements for alleviating fatigue in patients with MSA, but the beneficial effects last no more than 4 weeks. Frontiers Media S.A. 2022-01-11 /pmc/articles/PMC8788320/ /pubmed/35087463 http://dx.doi.org/10.3389/fneur.2021.755352 Text en Copyright © 2022 Pan, Mi, Ma, Sun and Chan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Pan, Jing
Mi, Tao-Mian
Ma, Jing-Hong
Sun, Hong
Chan, Piu
High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial
title High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial
title_full High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial
title_fullStr High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial
title_full_unstemmed High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial
title_short High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial
title_sort high-frequency repetitive transcranial magnetic stimulation over the left dorsolateral prefrontal cortex shortly alleviates fatigue in patients with multiple system atrophy: a randomized controlled trial
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788320/
https://www.ncbi.nlm.nih.gov/pubmed/35087463
http://dx.doi.org/10.3389/fneur.2021.755352
work_keys_str_mv AT panjing highfrequencyrepetitivetranscranialmagneticstimulationovertheleftdorsolateralprefrontalcortexshortlyalleviatesfatigueinpatientswithmultiplesystematrophyarandomizedcontrolledtrial
AT mitaomian highfrequencyrepetitivetranscranialmagneticstimulationovertheleftdorsolateralprefrontalcortexshortlyalleviatesfatigueinpatientswithmultiplesystematrophyarandomizedcontrolledtrial
AT majinghong highfrequencyrepetitivetranscranialmagneticstimulationovertheleftdorsolateralprefrontalcortexshortlyalleviatesfatigueinpatientswithmultiplesystematrophyarandomizedcontrolledtrial
AT sunhong highfrequencyrepetitivetranscranialmagneticstimulationovertheleftdorsolateralprefrontalcortexshortlyalleviatesfatigueinpatientswithmultiplesystematrophyarandomizedcontrolledtrial
AT chanpiu highfrequencyrepetitivetranscranialmagneticstimulationovertheleftdorsolateralprefrontalcortexshortlyalleviatesfatigueinpatientswithmultiplesystematrophyarandomizedcontrolledtrial